Michael Saylor, executive chairman of Strategy, predicts Bitcoin will appreciate about 30% per year for the next 20 years, potentially making today's price negligible by 2045. He proposed a Bitcoin capital gains fund that would pay dividends based on Bitcoin's price gains, aiming to attract income-focused investors by turning Bitcoin into a yield-generating asset. Strategy currently holds around 500,000 BTC, acquired through over $30 billion in fundraising since 2020, with plans to increase holdings by nearly 29% through new share issuance. This approach could further normalize corporate Bitcoin adoption but carries dilution risks if Bitcoin's price declines or stalls.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
